Abstract
Duchenne and Becker muscular dystrophy are X-linked muscle-wasting disorders that arise from mutations in the gene coding for dystrophin. The incidence of Duchenne muscular dystrophy (DMD) is approximately 1 in 3500 live male births, one-third of which are sporadic with no previous family history. In the absence of dystrophin, patients with DMD exhibit progressive muscle fiber necrosis which, despite the regenerative capacity of the muscle during the early stages, leads to the gradual deposition of fibrotic and fat tissues and the loss of ambulation around 11 years of age. Death due to respiratory failure usually occurs by the third decade (Emery, 1993). Becker muscular dystrophy (BMD), the incidence of which is approximately 10-fold less than DMD, follows a generally much milder course due to the presence of a partially functional form of dystrophin. Generally the BMD phenotype tends to be much more varied, both with regard to the age of onset and clinical presentation, and some patients never lose the ability to walk.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acsadi, G., Dickson, G., Love D.R. et al. (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature, 352, 815–18.
Acsadi, G., Jani, A., Massie, B. et al. (1994) A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet., 3, 579–84.
Ahn, A.H. and Kunkel, L.M. (1993) The structural and functional diversity of dystrophin. Nature Genet., 3, 283–91.
Ahn, A.H., Yoshida, M., Anderson, M.S. et al. (1994) Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosom 8q23–24. Proc. Natl Acad. Sci. USA, 91, 4446–50.
Bakker, A.J., Head, S.I., Williams, D.A. and Stephenson, D.G. (1993) Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J. Physiol. (Lond), 460, 1–13.
Barnea, E., Zuk, D., Simantov, R., Nudel, U. and Yaffe, D. (1990) Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron, 5, 881–8.
Barr, E., Carroll, J., Kalyncych, A.M. et al. (1994) Efficent catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther., 1, 51–8.
Blake, D.J., Tinsley, J.M. and Davies, K.E. (1993) The emerging family of dystrophin-related proteins. Trends Cell Biol., 4, 19–23.
Bulfield, G., Siller, W.G., Wight, P.A.L. and Moor, K.J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA, 81, 1189–92.
Byers, T.J., Kunkel, L.M. and Watkins, S.C. (1991) The subcellular distribution of dystrophin in mouse skeletal cardiac and smooth muscle. J. Cell Biol., 115, 411–21.
Campanelli, J.T., Roberds, S.L., Campbell, K.P. and Scheller, R.H. (1994) A Role for dystrophin-associated glycoproteins and utrophin in agrin-Induced AChR clustering. Cell, 77, 663–74.
Clerk, A., Morris, G.E., Dubowitz, V., Davies, K. and Sewry, C.A. (1993) Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem. J., 25, 554–61.
Corrado, K., Mills, P.L. and Chamberlain, J.S. (1994) Deletion analysis of the dystrophin-actin binding domain. FEBS Lett., 344, 255–60.
Cox, GA., Cole, N.M., Matsumura, K. et al. (1993) Over expression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature, 364, 725–9.
Cross, R.A., Stewart, M. and Kendrick-Jones, J. (1990) Structural predictions for the central domain of dystrophin. FEBS Lett., 262, 87–92.
Danko, I., Fritz, J.D., Latendresse, J.S., Herweijer, H., Schultz, E. and Wolff, J.A. (1993) Dystrophin expression improves myofibre survival in mdx muscle following intramuscular plasmid DNA injection. Hum. Mol. Genet., 2, 2055–61.
Davis, H.L., Demeneix, B.A., Quantin, B., Coulombe, J. and Whalen, R.G. (1993) Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Human Gene Ther., 4, 733–40.
Dickson, G. and Dunckley, M.G. (1993) Human dystrophin gene transfer:genetic correction of dystrophin deficiency, in Molecular and Cell Biology of Muscular Dystrophy, (ed. T. Partridge), Chapman & Hall, London, pp. 283–302.
Dickson, G., Love, D.R., Davies, K.E., Wells, K.E., Piper, T.A. and Walsh, F.S. (1991) Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Human Genet., 88, 53–8.
Dickson, G., Azad, A., Morris, G.E., Simon, H., Noursadeghi, M. and Walsh, F.S. (1992) Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J. Cell Sci., 103, 1223–33.
Dunckley, M.G and Dickson, G. (1994) Retroviral-mediated gene transfer and Duchenne muscular dystrophy, in Gene Therapeutics, (ed. J.A. Wolff), Birkhauser Boston, pp. 391–410.
Dunckley, M.G., Love, D.R., Davies, K.E., Walsh, F.S., Morris, G.E. and Dickson, G. (1992) Retroviral-mediated transfer of a dystrophin minigene into mdx myoblasts in vitro. FEBS Lett., 296, 128–34.
Dunckley, M.G., Wells, D.J., Walsh, F.S. and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet., 2, 717–23.
Dunckley, M.G., Wells, K.E., Piper, T.A., Wells, D.J. and Dickson, G. (1994) Independent localization of dystrophin N- and C-terminal regions to the sarcolemma of mdx mouse myofibres in vivo. J. Cell Sci., 107, 1469–75.
Eglitis, M.A., Kantoff, P., Gilboa, E. and Anderson, W.F. (1985) Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science, 230, 1395–8.
Emery, A.E.H. (1993) Duchenne Muscular Dystrophy, 2nd edn, Oxford University Press, Oxford.
Engel, A.G. (1993) Gene therapy for Duchenne dystrophy. Ann. Neurol., 34, 3–4.
England, S.B., Nicholson, L.V.B., Johnson, M.A. et al. (1990) Very mild muscular dystrophy associated with deletion of 46% of dystrophin. Nature, 343, 180–2.
Ervasti, J.M. and Campbell, K.P. (1991) Membrane organization of the dystrophinglycoprotein complex. Cell, 66, 1121–31.
Ervasti, J.M. and Campbell, K.P. (1993) Dystrophin and the membrane skeleton. Curr. Opin. Cell Biol., 5, 82–7.
Feener, C.A., Koenig, M. and Kunkel, L.M. (1989) Alternative splicing of human dystrophin mRNA generates isoforms at the carboxyterminus. Nature, 338, 509–11.
Franco, A. and Lansman, J.B. (1990) Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature, 344, 670–3.
Gaschen, F.P., Hoffman, E.P., Gorospe, J.R. et al. (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J. Neurol. Sci., 110, 149–59.
Gee, S.H., Montanaro, F., Lindebaum, M.H. and Carbonetto, S. (1994) Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell, 77, 675–86.
Gilbert, J.C., Takada, T., Stein, J.E., Langer, R. and Vacanti, J.P. (1993) Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation, 56, 423–7.
Hemmings, L., Kuhlman, P.A. and Critchley, D.R. (1992) Analysis of the actinbinding domain of α-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J. Cell Biol., 116, 1369–80.
Hoffman, E.P., Brown, R.H. and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919–28.
Hutter, O.F. (1992) The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence. J. Inherit. Met. Dis., 15, 565–77.
Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W. and Campbell, K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696–702.
Karpati, G., Adjukovic, D., Arnold, D. et al. (1993a) Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol, 34, 8–17.
Karpati, G., Carpenter, S., Morris, G.E, Davies, K.E., Guerin, C. and Holland, P. (1993b) Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol, 52, 119–28.
Khurana, T.S. (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromusc. Disord., 1, 185–94.
Klietsch, R., Ervasti, J.M., Arnold, W., Campbell, K.P. and Jorgensen, A.O. (1993) Dystrophin-glycoprotein complex and laminin colocalise to the sarcolemma and transverse tubules of cardiac muscle. Circ. Res., 72, 349–60.
Koenig, M., Monaco, A.P. and Kunkel, L.M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell, 53, 219–28.
Koenig, M. and Kunkel, L.M. (1990) Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem., 265, 4560–6.
Koenig, M., Beggs, A.H., Moyer, M. et al. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet., 45, 498–506.
Kozarsky, K.F. and Wilson, J.M. (1993) Gene therapy: adenovirus vectors (review). Curr. Opin. Genet. Dev., 3, 499–503.
Law, D.J., Allen, D.L. and Tidball, J.G. (1994) Talin vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J. Cell Sci., 107, 1477–83.
Lee, C.C., Pearlman, J.A., Chamberlain, J.S. and Caskey, C.T. (1991) Expression of recombinant dystrophin and its localization to the cell membrane. Nature, 349, 334–6.
Levine, B.A., Moir, A.J.G., Patchell, V.B. and Perry, S.V. (1992) Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Lett., 298, 44–8.
Love, D.R., Hill, D.F., Dickson, G. et al. (l989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature, 339, 55–8.
Love, D.R., Blyth, B.C., Tinsley, J.M., Blake, D.J. and Davies, K.E. (1993) Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromusc. Disord., 3, 5–21.
Matsumura, K. and Campbell, K.P. (1993) Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in servere childhood muscular dystrophies. Neuromusc. Disord., 3, 109–18.
Matsumura, K., Ervasti, J.M., Ohlendieck, K., Kahl, S.D. and Campbell, K.P. (1992a) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature, 360, 588–91.
Matsumura, K., Tome, F.M.S., Collin, H. et al. (1992b) Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recesssive muscular dystrophy. Nature, 359, 320–2.
Menke, A. and Jockusch, H. (1991) Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature, 349, 69–71.
Miller, A.D. (1992) Human gene therapy comes of age. Nature, 357, 455–60.
Minetti, C., Beltrame, F., Marcenaro, G. and Bonilla, E. (1992) Dystrophin at the plasma membrane of human muscle fibers shows a costameric localization. Neuromusc. Disord., 2, 99–109.
Mizuno, Y., Yoshida, M., Nonaka, I., Hirai, S. and Ozawa, E. (1994) Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve, 17, 206–16.
Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H. and Kunkel, L.M. (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 2, 90–5.
Morgan, J.E. (1994) Cell and gene therapy in Duchenne muscular dystrophy. Hum. Gene Ther., 5, 165–73.
Morgan, R.A and Anderson, W.F. (1993) Human gene therapy (review). Annu. Rev. Biochem., 62, 191–217.
Ohlendieck, K. and Campbell, K.P. (1991) Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett., 283, 230–4.
Ohlendieck, K., Ervasti, J.M., Matsumura, K. et al. (1991) Dystrophin related protein is localised to neuromuscular junctions of adult skeletal muscle. Neuron, 7, 499–508.
Pardo, J.V., Siliciano, J.D. and Craig, S.W. (1983) A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements (‘costameres’) mark sites of attachment between myofibrils and sarcolemma. Proc. Natl Acad. Sci. USA, 80, 1008–12.
Partridge, T. (1991) Animal models of muscular dystrophy — what can they teach us? Neuropathol. Appl. Neurobiol., 17, 353–63.
Partridge, T.A., Morgan, J.E., Coulton, G.R., Hoffman, E.P. and Kunkel, L.M. (1989) Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature, 337, 176–9.
Pons, F., Robert, A., Marini, J.F. and Leger, J.J. (1994) Does utrophin expression in muscles of mdx mice during postnatal development functionaly compensate for dystrophin deficiency? J. Neurol. Sci., 122, 162–70.
Porter, G.A., Dmytrenko, G.M., Winkelmann, J.C. and Block, R.J. (1992) Dystrophin colocalises with ß-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J. Cell Biol., 117, 997–1005.
Quantin, B., Perricaudet, L.D., Tajbakhsh, S. and Mandel, J.L. (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl Acad. Sci. USA, 89, 2581–4.
Ragot, T., Vincent, N., Chafey, P. et al. (1993) Efficient adenovirus mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature, 361, 647–50.
Roberts, R.G., Coffey, A.J., Bobrow, M. and Bentley, D.R. (1993) Exon structure of the human dystrophin gene. Genomics, 16, 536–8.
Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C. et al. (1992) In vivo transfer of human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell, 68, 143–55.
Sato, O., Nonomura, Y., Kimura, S. and Maruyama, K. (1992) Molecular shape of dystrophin. J. Biocbem. (Tokyo), 112, 631–6.
Stedman, H.H., Sweeney, H.L., Shrager, J.B. et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536–8.
Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. and Briand, P. (1992) Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest., 90, 626–30.
Sunada, Y., Bernier, S.M., Kozak, C.A., Yamada, Y. and Campbell, K.P. (1994) Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem., 269, 13729–32.
Suzuki, A., Yoshida, M., Yamamoto, H. and Ozawa, E. (1992a) Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett., 308, 154–60.
Suzuki, A., Yoshida, M., Hayashi, K., Mizuno, Y., Hagiwara, Y. and Ozawa, E. (1992b) Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxyterminal portion of dystrophin. Eur. J. Biocbem., 220, 283–92.
Takemitsu, M., Koga, R., Ishiura, S., Nonaka, L, Arahata, K. and Sugita, H. (1994) Dystrophin-related protein in diaphragm, limb and myoblast transferred muscles of mdx mouse. Clin. Neurol., 34, 141–6.
Tinsley, J.M. and Davies, K.E. (1993) Utrophin: a potential replacement for dystrophin? Neuromusc. Disord., 3, 537–9.
Tome, F.M.S., Evangelista, T., Leclerc, A. et al. (1994) Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. [111], 317, 351–7.
Turner, P.R., Fong, P.Y., Denetclaw, W.F. and Steinhardt, R.A. (1991) Increased calcium influx in dystrophic muscle. J. Cell Biol., 115, 1701–12.
Valentine, B.A., Cooper, B.J., Cummings, J.F. and DeLahunta, A. (1990) Canine X-linked muscular dystrophy: morphologic lesions. J. Neurol. Sci., 97, 1–23.
Vincent, N., Ragot, T., Gilgencrantz, H. et al. (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet., 5, 130–4.
Weller, B., Karpati, G. and Carpenter, S. (1990) Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol Sci., 100, 9–15.
Wells, D.J. (1993) Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett., 332, 179–82.
Wells, D.J. and Goldspink, G. (1992) Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle. FEBS Lett., 306, 203–5.
Wells, D.J., Wells, K.E., Walsh, F.S. et al. (1992) Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum. Mol. Genet., 1(1), 35–40.
Wessel, H.B. (1990) Dystrophin: a clinical perspective. Ped. Neurol., 6, 3–12.
Wolff, J.A., Malone, R.W., Williams, P. et al. (1990) Direct gene transfer into mouse muscle in vivo. Science, 247, 1465–8.
Wolff, J.A., Williams, P., Ascadi, G., Jiao, S., Jani, A. and Chong, W. (1991) Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques, 11, 474–85.
Xu, H., Christmas, P., Wu, X.R., Wewer, U.M. and Engvall, E. (1994) Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl Acad. Sci USA, 91, 5572–6.
Yang, B., Ibraghivmov-Beskrovnaya, O., Moomaw, C.R., Slaugher, C.A. and Campbell, K.P. (1994a) Heterogeneity of the 5 9-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J. Biol. Chem., 269, 6040–4.
Yang, Y., Nunes, F.A., Berencsi, K., Gonczol, E., Engelhardt, J.F. and Wilson, J.M. (1994b) Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet., 7, 362–9.
Zabner, J., Couture, L.A., Gregory, R.A. et al. (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell, 75, 207–16.
Zhu, N., Liggit, D., Liu, Y. and Debs, R. (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science, 261, 209–11.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Dickson, G., Brown, S.C. (1995). Duchenne muscular dystrophy. In: Dickson, G. (eds) Molecular and Cell Biology of Human Gene Therapeutics. Molecular and Cell Biology of Human Diseases Series, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0547-7_14
Download citation
DOI: https://doi.org/10.1007/978-94-011-0547-7_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4242-0
Online ISBN: 978-94-011-0547-7
eBook Packages: Springer Book Archive